Answers are grounded in this paper and cite their sources.
SARS-COV-2 has created one of the most massive pandemics in modern history. There is a rapid accumulation of data on its epidemiology, clinical course, diagnosis, management, and complications. One of the sequelae of COVID-19 pneumonia and acute respiratory distress syndrome (ARDS) is pulmonary fibrosis. There is a dearth of accurate data on the prevalence of pulmonary fibrosis post-COVID-19. We report a patient who developed dyspnea secondary to pulmonary fibrosis after successful treatment of COVID-19 pneumonia.
No takes yet. Share an insight, caveat, or question.
Alhiyari et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: